These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37383388)

  • 1. Editorial: Translational research in thyroid cancer, Volume II.
    Cheng SY; Vasko V; Jensen KE
    Front Endocrinol (Lausanne); 2023; 14():1223976. PubMed ID: 37383388
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Translational Research in Thyroid Cancer.
    Vasko V; Kebebew E; Cheng SY; Jensen KE
    Front Endocrinol (Lausanne); 2020; 11():224. PubMed ID: 32351455
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncogenes in thyroid cancer.
    Kim DS; McCabe CJ; Buchanan MA; Watkinson JC
    Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):386-95. PubMed ID: 12969338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer.
    Yi HS; Chang JY; Kim KS; Shong M
    Korean J Intern Med; 2017 Sep; 32(5):780-789. PubMed ID: 28823142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspective.
    Ball DW
    Thyroid; 2009 Jun; 19(6):547-50. PubMed ID: 19499986
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular mechanisms in differentiated thyroid cancer.
    Xie J; Fan Y; Zhang X
    Front Biosci (Landmark Ed); 2016 Jan; 21(1):119-29. PubMed ID: 26709764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Double-edged swords: important factors connecting metabolic disorders and cancer development - from basic research to translational applications, volume II.
    Kung CP; Barnoud T; Yao CH; Bertolini I; Murphy ME
    Front Endocrinol (Lausanne); 2024; 15():1441828. PubMed ID: 38962679
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular pathogenesis of thyroid cancer: the significance of oncogenes, tumor suppressor genes, and genomic instability.
    Farid NR
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():1-12. PubMed ID: 8980991
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in molecular-based management of differentiated thyroid cancer.
    Xing M; Haugen BR; Schlumberger M
    Lancet; 2013 Mar; 381(9871):1058-69. PubMed ID: 23668556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene abnormalities in thyroid cancer].
    Namba H; Yamashita S
    Nihon Rinsho; 2007 Nov; 65(11):1967-72. PubMed ID: 18018556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in thyroid cancer.
    Kaplan MM
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):469-78. PubMed ID: 2261903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profiles in the management of papillary thyroid cancer.
    Lee JC; Gundara JS; Glover A; Serpell J; Sidhu SB
    Oncologist; 2014 Nov; 19(11):1141-7. PubMed ID: 25323484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Radiation as Risk Factor, Early Diagnosis, Therapy, and Follow-up of Differentiated Thyroid Cancer.
    Reiners C; Drozd V
    Front Endocrinol (Lausanne); 2021; 12():797969. PubMed ID: 34956102
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.
    Yip L
    J Surg Oncol; 2015 Jan; 111(1):43-50. PubMed ID: 25155423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational research using the sodium/iodide symporter in imaging and therapy.
    Chung JK; Kang JH
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):799-802. PubMed ID: 14770271
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: anaplastic carcinoma of the thyroid--will aurora B light a path for treatment?
    Nikiforov YE
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1243-5. PubMed ID: 15699543
    [No Abstract]   [Full Text] [Related]  

  • 17. Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF.
    Antonello ZA; Nucera C
    Oncogene; 2014 Nov; 33(47):5397-404. PubMed ID: 24362526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNAs in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, and Therapy.
    Mahmoudian-Sani MR; Jalali A; Jamshidi M; Moridi H; Alghasi A; Shojaeian A; Mobini GR
    Oncol Res Treat; 2019; 42(3):136-142. PubMed ID: 30799425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External radiation and thyroid neoplasia.
    Sarne D; Schneider AB
    Endocrinol Metab Clin North Am; 1996 Mar; 25(1):181-95. PubMed ID: 8907686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for thyroid cancer.
    Barzon L; Pacenti M; Boscaro M; Palù G
    Expert Opin Biol Ther; 2004 Aug; 4(8):1225-39. PubMed ID: 15268658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.